Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2018-2033)
2.2 Global Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2024-2033)
2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Next Generation Diabetes Therapy and Drug Delivery by Players
3.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2018-2023)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Next Generation Diabetes Therapy and Drug Delivery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2022
3.5 Global Key Players of Next Generation Diabetes Therapy and Drug Delivery Head office and Area Served
3.6 Global Key Players of Next Generation Diabetes Therapy and Drug Delivery, Product and Application
3.7 Global Key Players of Next Generation Diabetes Therapy and Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2024-2033)
5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2033)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
6.2.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023)
6.2.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033)
6.2.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
6.3.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023)
6.3.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033)
6.3.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
6.4.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)
6.4.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2033)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
7.2.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023)
7.2.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033)
7.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
7.3.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023)
7.3.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033)
7.3.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
7.4.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)
7.4.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2033)
8.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
8.2.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023)
8.2.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033)
8.2.3 China Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
8.3 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
8.3.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023)
8.3.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033)
8.3.3 China Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2033)
9.2 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
9.2.1 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023)
9.2.2 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033)
9.2.3 Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
9.3 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
9.3.1 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023)
9.3.2 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033)
9.3.3 Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
9.4 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Region
9.4.1 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2018-2023)
9.4.3 Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.1.5 Johnson & Johnson Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.3.5 Medtronic Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.4.5 Sanofi Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.5.5 Novo Nordisk Recent Developments
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Details
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.6.5 MannKind Corporation Recent Developments
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Details
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.7.5 Enteris BioPharma Recent Developments
11.8 Dexcom
11.8.1 Dexcom Company Details
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.8.5 Dexcom Recent Developments
11.9 Senseonics
11.9.1 Senseonics Company Details
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.9.5 Senseonics Recent Developments
11.10 Medtech
11.10.1 Medtech Company Details
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.10.5 Medtech Recent Developments
11.11 Synertech
11.11.1 Synertech Company Details
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.11.5 Synertech Recent Developments
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Details
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.12.5 Zosano Pharma Recent Developments
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Details
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.13.5 Relmada Therapeutics Recent Developments
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.14.5 Eli Lilly and Company Recent Developments
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Details
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
11.15.5 Transdermal Specialties Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Inhalable Insulin
Table 3. Key Players of Oral Insulin
Table 4. Key Players of Insulin Patches
Table 5. Key Players of CGM Systems
Table 6. Key Players of Artificial Pancreas
Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2018-2023)
Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2024-2033)
Table 13. Next Generation Diabetes Therapy and Drug Delivery Market Trends
Table 14. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
Table 15. Next Generation Diabetes Therapy and Drug Delivery Market Challenges
Table 16. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
Table 17. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players (2018-2023)
Table 19. Global Top Next Generation Diabetes Therapy and Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2022)
Table 20. Global Next Generation Diabetes Therapy and Drug Delivery Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Next Generation Diabetes Therapy and Drug Delivery, Headquarters and Area Served
Table 23. Global Key Players of Next Generation Diabetes Therapy and Drug Delivery, Product and Application
Table 24. Global Key Players of Next Generation Diabetes Therapy and Drug Delivery, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2018-2023)
Table 28. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2024-2033)
Table 30. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2018-2023)
Table 32. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2024-2033)
Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Next Generation Diabetes Therapy and Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Next Generation Diabetes Therapy and Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Next Generation Diabetes Therapy and Drug Delivery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2024-2033) & (US$ Million)
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product
Table 69. Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 70. Johnson & Johnson Recent Developments
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product
Table 74. Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 75. Abbott Laboratories Recent Developments
Table 76. Medtronic Company Details
Table 77. Medtronic Business Overview
Table 78. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product
Table 79. Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 80. Medtronic Recent Developments
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product
Table 84. Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 85. Sanofi Recent Developments
Table 86. Novo Nordisk Company Details
Table 87. Novo Nordisk Business Overview
Table 88. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product
Table 89. Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 90. Novo Nordisk Recent Developments
Table 91. MannKind Corporation Company Details
Table 92. MannKind Corporation Business Overview
Table 93. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product
Table 94. MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 95. MannKind Corporation Recent Developments
Table 96. Enteris BioPharma Company Details
Table 97. Enteris BioPharma Business Overview
Table 98. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 99. Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 100. Enteris BioPharma Recent Developments
Table 101. Dexcom Company Details
Table 102. Dexcom Business Overview
Table 103. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product
Table 104. Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 105. Dexcom Recent Developments
Table 106. Senseonics Company Details
Table 107. Senseonics Business Overview
Table 108. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product
Table 109. Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 110. Senseonics Recent Developments
Table 111. Medtech Company Details
Table 112. Medtech Business Overview
Table 113. Medtech Next Generation Diabetes Therapy and Drug Delivery Product
Table 114. Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 115. Medtech Recent Developments
Table 116. Synertech Company Details
Table 117. Synertech Business Overview
Table 118. Synertech Next Generation Diabetes Therapy and Drug Delivery Product
Table 119. Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 120. Synertech Recent Developments
Table 121. Zosano Pharma Company Details
Table 122. Zosano Pharma Business Overview
Table 123. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 124. Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 125. Zosano Pharma Recent Developments
Table 126. Relmada Therapeutics Company Details
Table 127. Relmada Therapeutics Business Overview
Table 128. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product
Table 129. Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 130. Relmada Therapeutics Recent Developments
Table 131. Eli Lilly and Company Company Details
Table 132. Eli Lilly and Company Business Overview
Table 133. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product
Table 134. Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 135. Eli Lilly and Company Recent Developments
Table 136. Transdermal Specialties Company Details
Table 137. Transdermal Specialties Business Overview
Table 138. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product
Table 139. Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023) & (US$ Million)
Table 140. Transdermal Specialties Recent Developments
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type: 2022 VS 2033
Figure 3. Inhalable Insulin Features
Figure 4. Oral Insulin Features
Figure 5. Insulin Patches Features
Figure 6. CGM Systems Features
Figure 7. Artificial Pancreas Features
Figure 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2022 VS 2033
Figure 10. Diagnostic/Clinics Case Studies
Figure 11. ICUs Case Studies
Figure 12. Home Healthcare Case Studies
Figure 13. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region: 2022 VS 2033
Figure 17. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2022
Figure 18. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2022
Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
Figure 22. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
Figure 23. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2018-2033)
Figure 24. United States Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
Figure 28. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
Figure 29. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2018-2033)
Figure 30. Germany Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
Figure 38. China Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
Figure 39. Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
Figure 41. Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
Figure 42. Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2018-2033)
Figure 43. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2018-2033)
Figure 53. Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 60. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 61. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 63. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 64. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 65. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 66. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 67. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 68. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 69. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 70. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 71. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 72. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 73. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed